Uganda MVP Access
A controlled stakeholder demonstration of how accepted healthcare evidence can generate reusable proof, implementation learning, cost intelligence, and governed shadow payment-readiness.
This access point is for authorized presenters, demo team members, Uganda stakeholders, and selected African partners using the Uganda MVP to understand how GLOHBX and Global Health Catalyst can help convert health priorities into governed, auditable, proof-before-payment pathways across cancer, Non-Communicable Diseases, and whole-person health.
Why this MVP matters
Turning value into verified health impact
Many diaspora families, global allies, philanthropies, and institutional partners want to support healthcare in Africa. Yet they often face the same problem: money can move while authorization, delivery, documentation, evidence, and accountability remain uncertain.
Traditional remittance and modern financial technology can make cross-border value movement easier. Healthcare financing requires a further question:
What must be true before value can responsibly become payment and verified health impact?
GLOHBX is rail-agnostic.
It can integrate with approved payment and funding rails while establishing the governed pathway that connects sponsor intent to authorized care, verified service delivery, accepted proof, disciplined costing, and controlled payment-readiness.
What the MVP Demonstrates
The Uganda MVP demonstrates an evidence-to-financing control chain:
The MVP evaluates each stage from governed case facts. A downstream instruction cannot create, replace, or bypass authorization, redemption, evidence, reviewer acceptance, or accepted-only closeout.
What You Will See
Governed care authorization
A restricted care right connects an approved sponsor, beneficiary, service, and provider.
Accepted service-event proof
The service event is captured, evidenced, and reviewed before it can enter accepted-only closeout.
Learning and cost intelligence
The accepted event generates structured implementation observations and a provisional cost per accepted event, including comparison with a seeded fiscal ceiling.
Shadow payment-readiness
The MVP evaluates service, evidence, costing, provider, approval, and simulated custody controls before generating a non-executable provider payment instruction.
Case Readiness Is Not Pathway Readiness
A controlled event may satisfy the rules for accepted-only closeout and shadow payment-readiness. That does not mean the wider health-service pathway is ready for live activation or scale.
Repeated cases, validated costing, stable evidence quality, provider capacity, governance, custody and payment controls, operational continuity, and partner approvals are still required.
Case status
Shadow Payment Ready
Pathway status
Readiness Building
Partner Review Lens
As you review the MVP, consider which readiness gate your institution could help strengthen:
Every partner should strengthen a readiness gate before strengthening the story.
Institutional Roles
Global Health Catalyst
Global Health Catalyst is the platform operator and proof-before-payment architecture lead. It supports the digital workflow, verification logic, implementation learning, partner coordination, and financing-readiness pathway.
Uganda Cancer Institute
Uganda Cancer Institute is the clinical, operational, and co-design anchor for service rules, standard operating procedures, evidence requirements, costing validation, accepted-only closeout, and future activation-readiness gates.
This MVP uses simulated sponsor value and controlled demonstration data.
It may display
- Provisional accepted-event costs
- A seeded fiscal ceiling
- Simulated custody references
- Simulated rail references
- A non-executable provider payment instruction
It does not
- Move live money
- Display or transfer a live custodian balance
- Complete a remittance
- Execute a payment rail
- Settle a provider
- Create a government outcome-payment obligation
Acronyms used in this MVP
GLOHBX — Global Health Bond Exchange
GHC — Global Health Catalyst
UCI — Uganda Cancer Institute
© 2026 GLOHBX. Limited-access stakeholder demonstration.